BridgeBio Pharma Inc (BBIO)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -82.506 | -67.211 | -65.549 | -58.831 | -110.004 |
| Return on Equity (%) | -110.014 | -154.735 | 147.891 | 45.602 | 49.738 |
| Return on Invested Capital (%) | -112.518 | -88.546 | -79.559 | -81.639 | -150.483 |
| Operating Margin (%) | -689.892 | -5683.513 | -774.106 | -520.572 | -6148.146 |
| Net Profit Margin (%) | -642.473 | -5439.738 | -806.901 | -619.698 | -6913.92 |
| Book Value Per Share | 3.849 | 0.878 | -6.19 | -8.456 | -7.868 |
| Earnings Per Share | -2.107 | -3.653 | -3.825 | -3.195 | -3.697 |
| Cash Per Share | 2.942 | 2.899 | 2.677 | 2.501 | 2.161 |
| Working Capital Per Share | 4.11 | 4.454 | 5.125 | 2.838 | 1.918 |
| Operating Profit Per Share | 0.308 | 0.067 | 0.47 | 0.509 | 0.039 |
| EBIT Per Share | -2.334 | -4.115 | -3.987 | -3.218 | -3.755 |
| EBITDA Per Share | -2.334 | -4.115 | -3.987 | -3.218 | -3.755 |
| Free Cash Flow Per Share | -2.066 | -3.591 | -3.537 | -3.196 | -3.727 |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 123.66M | 122.85M | N/A | 150.63M | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Shares Outstanding | 150.63M | N/A | N/A | 173.97M | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | -6714.732 | N/A | N/A | N/A | -6.01 | N/A | N/A |
| Net Profit Margin (%) | N/A | -7675.575 | N/A | N/A | N/A | -16.681 | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 6.93B |
| Price to Earnings Ratio | -10.68 |
| Price to Sales Ratio | 738.62 |
| Price to Cash Ratio | 18.27 |
| Price to Book Ratio | -5.12 |
| Dividend Yield | - |
| Shares Outstanding | 188.99M |
| Average Volume (1 week) | 2.21M |
| Average Volume (1 Month) | 2.9M |
| 52 Week Change | -0.03% |
| 52 Week High | 41.04 |
| 52 Week Low | 21.62 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
